Delivery Order HHSN271201600005I-75N95018F00002
Award Date
6/1/18
Potential Completion Date
8/30/20
Potential Value
$1.7M
Funding Federal Agency
National Institute of Neurological Disorders and Stroke
Contracting Federal Agency
National Institute on Drug Abuse
Awardee
PPD Development LP
Ultimate Awardee
Not listed
NAICS Category
541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Cape Fear, NC 28401, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
2
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $2,320,561.04 cost-plus-fixed-fee delivery order contract awarded by the National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke to PPD Development LP, a global contract research organization. The contract is for protocol development, finalization, database build, and bioanalytical methods development in support of a Phase I single ascending dose clinical trial for a neurotherapeutic product. This work falls under the larger NIH Phase I Clinical...
This contract award to PPD Development LP by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), is for Phase I clinical trials in the development of neurotherapeutics. The $433,977 firm-fixed-price delivery order is part of a larger indefinite delivery/indefinite quantity (ID/IQ) contract for this program area. The contract supports administrative and overall clinical operations, with a period of performance through June 30,...
This is a $3,265,588.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a part of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS), to PPD Development LP, a global contract research organization. The contract is for a first-in-human randomized, double-blind, placebo-controlled single ascending dose (SAD) Phase I study on the development of neurotherapeutics. The contract is not set aside and is...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $500,263.64 Delivery Order contract to PPD Development LP, a global contract research organization (CRO), for clinical site and study monitoring services in support of research partnerships for global mental health. The contract has a period of performance from September 28, 2018 to September 27, 2023 and is a labor hours type contract. PPD Development LP has provided over $500...
This is a cost-plus-fixed-fee definitive contract awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to PPD Development LP, a global contract research organization (CRO), for R&D services related to biomedical basic research. The $27,437,431.92 contract has a performance period ending on October 31, 2021 and is not set aside for any specific business type. PPD Development LP has been awarded over $500 million in prime federal...
This is a $324,420.00 firm fixed-price delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to PPD Development LP, a global contract research organization (CRO). The contract is for research and development services related to clinical studies in the Blueprint MedTech program, including clinical study protocol development. The contract has a 5-year period of performance from June 17, 2024 to June 16, 2029, with a base period and two option units. PPD...
This is a firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract, valued at $696,693.16, was awarded to PPD Development LP, a global contract research organization (CRO), to provide PPD development site and study monitoring services. The contract has no set-aside designation and is part of several indefinite delivery...
This is a $5,758,524.34 delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to PPD Development LP, a global contract research organization (CRO). The contract is to provide monitoring services for a Phase III clinical trial, specifically trial A5300B/PHOENIX. It is a cost-plus-fixed-fee contract with an ultimate completion date of December 14, 2025. The contract was awarded on April 15, 2019 and is not...
This is a $1,859,402 task order award under the National Institute of Allergy and Infectious Diseases' (NIAID) Early Phase Clinical Trial Units (EPCTU) indefinite delivery vehicle (IDV) contract. The prime contractor, PPD Development LP, is a global contract research organization that provides comprehensive clinical trial and research support services to federal agencies. This cost-plus-fixed-fee delivery order does not have a set-aside designation. PPD will perform the work in Cape Fear,...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to PPD Development LP, a global contract research organization (CRO). The $2,791,811.00 cost-plus-fixed-fee delivery order contract is for the implementation of Phase 0 to Phase II clinical trials, including proof-of-concept studies in healthy and diseased human populations, both domestically and internationally, supported by bioanalysis as needed. Phase III studies may...